id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0122-0005,FDA,FDA-2004-D-0122,Compliance Guidance for Small Business Entities on Labeling Over-the-Counter Human Drug Products; Availability,Notice,NAD-Notice of Availability of Data,2009-05-13T04:00:00Z,2009,5,2009-05-13T04:00:00Z,,2009-05-13T18:53:59Z,E9-11089,0,0,090000648098e77b
FDA-2004-D-0122-0006,FDA,FDA-2004-D-0122,Labeling OTC Human Drug Products; Small Entity Compliance Guide:  Guidance for Industry,Other,Guidance,2009-05-12T04:00:00Z,2009,5,2009-05-13T04:00:00Z,,2020-05-07T18:47:21Z,,0,0,090000648098f90f